<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Pipobroman</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00236</strong>&#160; (APRD00693)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>An antineoplastic agent that acts by alkylation. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00236/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00236/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00236.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00236.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00236.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00236.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00236.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00236">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Vercite</td><td>Abbott Laboratories</td></tr><tr><td>Vercyte</td><td>Abbott Laboratories</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>CAS number</th><td>54-91-1</td></tr><tr><th>Weight</th><td>Average: 356.054<br>Monoisotopic: 353.95785306</td></tr><tr><th>Chemical Formula</th><td>C<sub>10</sub>H<sub>16</sub>Br<sub>2</sub>N<sub>2</sub>O<sub>2</sub></td></tr><tr><th>InChI Key</th><td>NJBFOOCLYDNZJN-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one</div></td></tr><tr><th>SMILES</th><td><div class="wrap">BrCCC(=O)N1CCN(CC1)C(=O)CCBr</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Heterocyclic Compounds</td></tr><tr><th>Class</th><td>Diazinanes</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Diazinanes</td></tr><tr><th>Alternative parents</th><td>Piperazines; Tertiary Carboxylic Acid Amides; Tertiary Amines; Polyamines; Carboxylic Acids; Enolates; Organobromides; Alkyl Bromides</td></tr><tr><th>Substituents</th><td>tertiary carboxylic acid amide; carboxamide group; tertiary amine; carboxylic acid derivative; enolate; polyamine; carboxylic acid; organonitrogen compound; organohalogen; organobromide; amine; alkyl halide; alkyl bromide</td></tr><tr><th>Classification description</th><td>This compound belongs to the diazinanes. These are organic compounds containing diazinane, a six-membered saturated heterocycle containing four carbon atoms and two nitrogen atoms.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of polycythaemia vera and refractory chronic myeloid leukaemia.</td></tr><tr><th>Pharmacodynamics</th><td>Pipobroman is an antineoplastic agent. Specifically it is a piperazine derivative with a chemical structure close to that of many DNA alkylating agents. Pipobroman has well documented clinical activity against polycythemia vera and essential thrombocythemia.</td></tr><tr><th>Mechanism of action</th><td>The mechanism of action is uncertain but pipobroman is thought to alkylate DNA leading to disruption of DNA synthesis and eventual cell death.</td></tr><tr><th>Absorption</th><td>Well absorbed from the GI tract.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>Symptoms of overdose include hematologic toxicity, especially with chronic overdosage.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9197</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9859</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.5115</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.5493</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.52</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9347</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.5366</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.9097</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.5765</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.6178</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.892</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8645</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9468</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.6421</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8322</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.8849</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          AMES toxic 
        </td>
        <td>
            0.9107
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9059
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9427
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          3.1778 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.829
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8346
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Abbott laboratories pharmaceutical products div</li></ul></td></tr><tr><th>Packagers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Dosage forms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01193">Acebutolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00335">Atenolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00195">Betaxolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01295">Bevantolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00612">Bisoprolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00521">Carteolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01136">Carvedilol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00187">Esmolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00598">Labetalol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00264">Metoprolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01203">Nadolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01580">Oxprenolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01359">Penbutolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00960">Pindolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB01297">Practolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00571">Propranolol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00489">Sotalol</a></td><td>Antagonism</td></tr><tr><td><a href="/drugs/DB00373">Timolol</a></td><td>Antagonism</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>